Predict your next investment

Corporation
HEALTHCARE | Medical Facilities & Services / Specialized Healthcare Services
vantageoncology.com

See what CB Insights has to offer

Executives

10

Board of Directors

3

Vantage Oncology Board of Directors

3 Board of directors

Vantage Oncology has 3 board of directors, including Harry Eichelberger.

Name

Firm

Work History

Other Seats

Harry Eichelberger

Founder of Archimedes Health Investors, a healthcare-focused private equity firm. Harry has been an investor in healthcare companies for 13 years, including companies such as SmartPak, Physician's Oncology Services, AccentCare Home Health, Accretive Health, Jazz Pharmaceuticals, and RainTree Oncology Services. He has also led interactions with health policymakers in Washington as a past board member of the Partnership for Quality Home Healthcare.

Vantage Oncology

Michael Aspinwall

Vantage Oncology

Steven Gruber

s PartnersPrincipals Vice President AssociatesInvestor Relations Capital Markets LegalOperations and Finance Managing Partners J. Taylor Crandall J. Taylor Crandall is a Managing Partner of Oak Hill Capital Partners and has been part of the firm since 1986. Mr. Crandall has senior responsibility for originating, structuring and managing investments for the firm's Media and Telecom and Technology industry groups. Prior to joining Oak Hill, Mr. Crandall was a Vice President with the First National Bank of Boston, where he managed a leveraged buyout group and the bank's Dallas energy office. Mr. Crandall earned a B.A. degree, magna cum laude, from Bowdoin College, where he has served on the Board of Overseers.</br></br>Back to Top</br>Steven B. Gruber Steven B. Gruber is a Managing Partner of Oak Hill Capital Partners and has been a part of the firm since 1990. Mr. Gruber has senior responsibility for originating, structuring and managing investments for the firm's Healthcare and Business and Financial Services industry groups. Prior to joining Oak Hill, Mr. Gruber previously was a Managing Director and Co-Head of High Yield Securities at Lehman Brothers and a Managing Director of its merchant banking group, as well as a member of Lehman Brotherss Investment Committee. He earned a B.A. degree from the University of Michigan and a M.B.A. from the University of Chicago Graduate School of Business, where he was a Merrill Fellow.</br></br>Back to Top</br>Denis J. Nayden Denis J. Nayden is a Managing Partner of Oak Hill Capital Partners and has been with the firm since 2003. Mr. Nayden co-heads the groups focused on investments in Basic Industries and Business and Financial Services industry groups. Prior to joining Oak Hill, he was Chairman and Chief Executive Officer of GE Capital, where he was responsible for 20 separate businesses representing $555 billion of aggregate assets and 90,000 employees in 35 countries. During his 26-year tenure at General Electric Company. Mr. Nayden also served as Chief Operating Officer (1994-2000\ Executive Vice President (1989-1994\ Senior Vice President and General Manager in the Structured Finance Group (1987-1989\ Vice President and General Manager in the Corporate Finance Group (1987-1989\ and Marketing Administrator for Air/Rail Financing as well as various other positions of increasing responsibility (1977-1987). Mr. Nayden earned a B.A. degree in English, magna cum laude, in 1976 and a M.B.A. in Finance in 1977 from the University of Connecticut, where he serves on the Board of Trustees.</br></br>Back to Top</br>Mark A. Wolfson Mark A. Wolfson is a Managing Partner of Oak Hill Capital Partners and has been working with the firm since 1992. Dr. Wolfson serves as a broad-based senior advisor across all of the business verticals. Dr. Wolfson has taught at the Stanford Graduate School of Business since 1977, including a term as the Dean Witter Professor and a term as Associate Dean. He also has taught at Harvard Business School and the University of Chicago and has been a Visiting Scholar at M.I.T.'s Sloan School of Management and the Hoover Institution at Stanford University. Mr. Wolfson earned a B.S. degree and an M.A.S., in both cases at the top of his class, in accounting and finance from the University of Illinois and a Ph.D. from the University of Texas at Austin.

Vantage Oncology

Name

Harry Eichelberger

Michael Aspinwall

Steven Gruber

Firm

Work History

Founder of Archimedes Health Investors, a healthcare-focused private equity firm. Harry has been an investor in healthcare companies for 13 years, including companies such as SmartPak, Physician's Oncology Services, AccentCare Home Health, Accretive Health, Jazz Pharmaceuticals, and RainTree Oncology Services. He has also led interactions with health policymakers in Washington as a past board member of the Partnership for Quality Home Healthcare.

s PartnersPrincipals Vice President AssociatesInvestor Relations Capital Markets LegalOperations and Finance Managing Partners J. Taylor Crandall J. Taylor Crandall is a Managing Partner of Oak Hill Capital Partners and has been part of the firm since 1986. Mr. Crandall has senior responsibility for originating, structuring and managing investments for the firm's Media and Telecom and Technology industry groups. Prior to joining Oak Hill, Mr. Crandall was a Vice President with the First National Bank of Boston, where he managed a leveraged buyout group and the bank's Dallas energy office. Mr. Crandall earned a B.A. degree, magna cum laude, from Bowdoin College, where he has served on the Board of Overseers.</br></br>Back to Top</br>Steven B. Gruber Steven B. Gruber is a Managing Partner of Oak Hill Capital Partners and has been a part of the firm since 1990. Mr. Gruber has senior responsibility for originating, structuring and managing investments for the firm's Healthcare and Business and Financial Services industry groups. Prior to joining Oak Hill, Mr. Gruber previously was a Managing Director and Co-Head of High Yield Securities at Lehman Brothers and a Managing Director of its merchant banking group, as well as a member of Lehman Brotherss Investment Committee. He earned a B.A. degree from the University of Michigan and a M.B.A. from the University of Chicago Graduate School of Business, where he was a Merrill Fellow.</br></br>Back to Top</br>Denis J. Nayden Denis J. Nayden is a Managing Partner of Oak Hill Capital Partners and has been with the firm since 2003. Mr. Nayden co-heads the groups focused on investments in Basic Industries and Business and Financial Services industry groups. Prior to joining Oak Hill, he was Chairman and Chief Executive Officer of GE Capital, where he was responsible for 20 separate businesses representing $555 billion of aggregate assets and 90,000 employees in 35 countries. During his 26-year tenure at General Electric Company. Mr. Nayden also served as Chief Operating Officer (1994-2000\ Executive Vice President (1989-1994\ Senior Vice President and General Manager in the Structured Finance Group (1987-1989\ Vice President and General Manager in the Corporate Finance Group (1987-1989\ and Marketing Administrator for Air/Rail Financing as well as various other positions of increasing responsibility (1977-1987). Mr. Nayden earned a B.A. degree in English, magna cum laude, in 1976 and a M.B.A. in Finance in 1977 from the University of Connecticut, where he serves on the Board of Trustees.</br></br>Back to Top</br>Mark A. Wolfson Mark A. Wolfson is a Managing Partner of Oak Hill Capital Partners and has been working with the firm since 1992. Dr. Wolfson serves as a broad-based senior advisor across all of the business verticals. Dr. Wolfson has taught at the Stanford Graduate School of Business since 1977, including a term as the Dean Witter Professor and a term as Associate Dean. He also has taught at Harvard Business School and the University of Chicago and has been a Visiting Scholar at M.I.T.'s Sloan School of Management and the Hoover Institution at Stanford University. Mr. Wolfson earned a B.S. degree and an M.A.S., in both cases at the top of his class, in accounting and finance from the University of Illinois and a Ph.D. from the University of Texas at Austin.

Other Seats

Vantage Oncology

Vantage Oncology

Vantage Oncology

Vantage Oncology Management Team

10 Team Members

Vantage Oncology has 10 executives. Vantage Oncology's current Chief Executive Officer is Michael T Fiore.

Name

Work History

Title

Status

Michael T Fiore

Chief Executive Officer

Current

Brian Rizkallah

Chief Financial Officer

Current

Marshal D Salomon

Chief Financial Officer

Current

Christopher M. Rose

Chief Technology Officer

Current

Leslie E Botnick

Chief Medical Officer

Current

Name

Michael T Fiore

Brian Rizkallah

Marshal D Salomon

Christopher M. Rose

Leslie E Botnick

Work History

Title

Chief Executive Officer

Chief Financial Officer

Chief Financial Officer

Chief Technology Officer

Chief Medical Officer

Status

Current

Current

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.